Insulin aspart, recombinant Subcutaneous and Oxaliplatin Concentrate Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Oxaliplatin Concentrate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: oxaliplatin
Brand name: Eloxatin
Synonyms: Oxaliplatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Oxaliplatin Intravenous
- Insulin aspart, recombinant Subcutaneous-Oxandrin
- Insulin aspart, recombinant Subcutaneous-Oxandrolone
- Insulin aspart, recombinant Subcutaneous-Oxaprozin
- Insulin aspart, recombinant Subcutaneous-Oxaprozin Potassium
- Insulin aspart, recombinant Subcutaneous-Oxaprozin Tablets
- Oxaliplatin Concentrate Injection-Insulin degludec
- Oxaliplatin Concentrate Injection-Insulin Degludec (U-100) Prefilled Pens
- Oxaliplatin Concentrate Injection-Insulin Degludec (U-100) Vials
- Oxaliplatin Concentrate Injection-Insulin Degludec (U-200) Prefilled Pens
- Oxaliplatin Concentrate Injection-Insulin degludec and liraglutide
- Oxaliplatin Concentrate Injection-Insulin degludec and liraglutide Subcutaneous